Interestingly, patient 27 with a SLC2A1 mutation causing glucose transporter type 1 (GLUT1) deficiency syndrome, was initially suspected to have a neurometabolic disorder due to the presence of systemic hypoglycaemia, cerebellar ataxia, spasticity and mild intellectual disability. Here, SLC2A1 is linked to aceruloplasminemia.